Efficacy Testing
Predictive models of human disease
In collaboration with clinical thought leaders, SynecorLABS has developed and validated complex proprietary models of human diseases that replicate key aspects
of human pathophysiology unavailable elsewhere. SynecorLABS is committed to the ongoing development of other large models of human disease. These surgical and interventional models
are offered in addition to models of human disease in genetically modified swine.
- Validated, proprietary large animal models of human disease provide unique opportunity to truly demonstrate efficacy in preclinical setting
- Choose one from our extensive portfolio, or design a completely custom model to meet specific requirements
- Heart failure
- Wound healing
- Metabolic/Obesity
- Acute MI
- Renal failure
- Hypertension
- Stroke
- Neurologic injury
- Valve disorders
- Inflammation
- Bladder dysfunction
- Atherosclerosis
- Pulmonary edema
- Benign prostatic Hyperplasia
- Cystic fibrosis
SynecorLABS offers novel validated techniques to accelerate your research:
- In vivo qualitative and morphometric analysis with extremely high statistical correlation with histomorphometry
- Unique early warning histopathologic analysis for rapid assessment of your study's progress
- Industry leaders in obtaining and monitoring infection and immunological status before, during, and after studies are completed
- Highly experienced and responsive IACUC committee
SynecorLABS stands behind their talent and scientific excellence by offering cost effective and high value programs to develop novel customized large models of disease or complete a method transfer to another species. Projects will be customized to ensure that the clearest readout of efficacy with your test article will be obtained with endpoints which reproduce human disease as fully as possible.
